Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Mol Cell Cardiol. 2010 Dec 13;51(4):607–613. doi: 10.1016/j.yjmcc.2010.11.020

Table 1.

Evidence from mouse models suggesting roles of GSK-3s in the heart

Model Cardiac Phenotype
Cardiac-specific Tg-GSK-3β-S9A Suppressed or reversed cardiac hypertrophy in response to TAC, calcineurin activation, or adrenergic stimulation [10, 15]
Cardiac-specific Tg-GSK-3β-DN Induction of compensatory hypertrophy, inhibition of apoptosis and fibrosis, and increased cardiac contractility after PO [12]
Cardiac-specific Tg-GSK-3β Impaired post-natal cardiomyocyte growth and led to contractile dysfunction [14]
Cardiac-specific Tg-GSK-3α Inhibited cardiac growth and PO-induced cardiac hypertrophy yet increased fibrosis and apoptosis [17]
GSK-3β S9A KI Attenuated hypertrophy and HF under PO [13]
GSK-3αS21A KI Increased hypertrophy and HF under PO [13]
GSK-3β germline KO Died in mid gestation from inability to recruit pro-survival NF-κB signaling in setting of increased TNFβ production in response to pathogens [24]; In absence of pathogens, died in late gestation or immediately after birth due to near obliteration of the ventricular cavities by proliferating cardiomyocytes, DORV and VSD also seen [21]
GSK-3α KO Born without apparent cardiac abnormalities [21, 25]; Development of cardiac hypertrophy and contractile dysfunction after 2-months of age; PO-induced increased hypertrophy and HF; impaired beta-adrenergic responsiveness [23]
Inducible cardiac-specific GSK-3β KO Normal PO-induced hypertrophy; less LV dilatation and better-preserved LV function post MI; increased cardiomyocyte proliferation following PO and MI [22]
GSK-3β-S9A/GSK-3α S21A double KI Normal post MI hypertrophy [26]; attenuated pathological hypertrophy induced by chronic adrenergic stimulation [27]

Abbreviations: TG, transgenic; S9A, serine-9 mutated to alanine; S21A, serine-21 mutated to alanine; DN, dominant negative; KI, knock-in; KO, knockout; HF, heart failure; PO, pressure overload; DORV, double outlet right ventricle; VSD, ventricular septal defect; MI, myocardial infarction; LV, left ventricle. Please see text for additional abbreviations.